(Q34394102)

1 August 2017

1 reference

title

Octreotide LAR treatment throughout pregnancy in an acromegalic woman (English)

1 reference

1 August 2017

1 reference

Fassnacht M

1

1 reference

1 August 2017

Capeller B

2

1 reference

1 August 2017

Arlt W

3

1 reference

1 August 2017

Steck T

4

1 reference

1 August 2017

Allolio B

5

1 reference

1 August 2017

1 September 2001

1 reference

1 August 2017

Clinical Endocrinology

1 reference

1 August 2017

55

1 reference

1 August 2017

3

1 reference

1 August 2017

411-415

1 reference

Placental and pituitary growth hormone secretion during pregnancy in acromegalic women.

1 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01304.X

Growth-hormone and prolactin excess.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01304.X

Clinical review 22: Therapeutic options in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01304.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01304.X

21 January 2018

Central hyperthyroidism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01304.X

Pregnancy and the hyperprolactinemic woman

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01304.X

Pituitary diseases in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01304.X

Medical therapy for acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01304.X

The safety of bromocriptine in long-term use: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01304.X

10.1046/J.1365-2265.2001.01304.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference